South Asian HeArt Risk Assessment Project - Trial (SAHARA-Trial) (SAHARA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01841398|
Recruitment Status : Unknown
Verified June 2016 by Sonia Anand, McMaster University.
Recruitment status was: Active, not recruiting
First Posted : April 26, 2013
Last Update Posted : June 9, 2016
|Condition or disease||Intervention/treatment||Phase|
|Cardiovascular Diseases Diabetes Abdominal Obesity||Behavioral: Multimedia Lifestyle Improvement Behavioral: Usual Care||Not Applicable|
Introduction: Coronary heart disease (CHD) remains the major cause of disease burden globally, and the rising prevalence of obesity and adult onset diabetes is predicted to potentiate the CHD epidemic in developing countries, and in high risk populations, including people who originate from the Indian subcontinent (South Asians). More than 1.2 million people of South Asian origin live in Canada and they are the fastest growing group of non-white Canadians. Our previous work among South Asians has shown that, compared to white Caucasians in Canada, they suffer from a 2.5 times excess prevalence of elevated glucose (dysglycemia), and CHD. They also develop abnormal glucose, lipids (elevated apolipoprotein B & reduced apolipoprotein Al) and blood pressure at significantly lower body mass index values compared to white Caucasians (21 vs. 30). Successful interventions which prevent or improve myocardial infarction (MI) risk factors among South Asians are urgently needed.
Objectives: Among South Asian men and women ≥ 30 years who live in Canada we propose:
- To test the effectiveness of a culturally-tailored multimedia intervention designed to improve health behaviours including dietary habits, sedentary behaviours, physical activity, and tobacco use, in order to improve their MI risk factor profile.
- To test if knowledge of genetic risk for MI as determined by the 9p21 variant genotype influences behaviour change and MI risk factor profile.
- To determine the change in the MI risk score and clinical events including MI, death, development of new diabetes, and development of new hypertension over the 6 months follow-up.
Design & Methods: People of South Asian ancestry defined as people whose ancestors originate from the Indian subcontinent (India, Pakistan, Bangladesh and Sri Lanka) ≥ 30 years age will be eligible for SAHARA. Subjects with no access to e-mail, text messaging or smart phones and who have suffered previous coronary heart disease will be excluded. 330 subjects will undergo a brief cardiac risk factor assessment including collection of data on questionnaire, physical measurement (i.e. weight, height, waist and hip circumference, and blood pressure), and a blood sample will be collected to measure apolipoproteins and glucose. All eligible and consenting subjects will be randomized 1:1 to intervention versus control. The intervention group will include goal setting, self monitoring and participants will receive regular health messaging using electronic media regarding smoking, dietary habits & physical activity. The control group will receive usual advice and no regular health messaging. The intervention will last for 12 months after randomization and the effectiveness of this intervention will be evaluated using the change in the cardiac risk score after 12 months.
Summary: South Asians are the fastest growing group of Canadians. They suffer an excess prevalence of cardiac risk factors and MI at a younger age compared to people of European origin. The SAHARA project will enable us to use simple but validated tools to assess the MI risk profile among South Asian men and women from Ontario and British Columbia, and we will test a culturally-tailored multimedia intervention to determine if improvement in the MI risk factor profile can be achieved and sustained. If this intervention is successful it will be easily scalable, and has the potential to be delivered to a large proportion of the South Asian community in Canada.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||343 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||South Asian HeArt Risk Assessment Project - Trial|
|Study Start Date :||June 2012|
|Actual Primary Completion Date :||December 2014|
Active Comparator: Multimedia Lifestyle Improvement
Includes goal setting, self monitoring and participants will receive regular health messaging using electronic media regarding smoking, dietary habits & physical activity
Behavioral: Multimedia Lifestyle Improvement
Placebo Comparator: Usual Care
Includes usual advice and no regular health messaging.
Behavioral: Usual Care
Participant will be refered to SAHARA study website to get information on healthy lifestyle and to get regular update for the course of follow-up.
- Effectiveness of a 12 Month Culturally-Specific Multi-media Intervention on Heart Health Risk [ Time Frame: Baseline and 12 months from randomization ]
To test the effectiveness of a 12 month culturally-specific multi-media intervention which provides health messaging and feedback regarding optimal strategies for individuals greater than 30 years to improve their dietary habits, sedentary behaviours, physical activity, and tobacco use.
Outcome measure (heart risk score) will be assessed based on the Interheart Modifiable Risk Score assessed at baseline and 12 months from randomization
- Influence of Knowledge of Personal Genetic Risk for Myocardial Infarction on Health Behaviours [ Time Frame: Baseline and 12 months from randomization ]
To determine if knowledge of personal genetic risk for Myocardial Infarction (MI)and Diabetes influences the health behaviours associated with MI risk factors.
Outcome measure (health behaviour) will be assessed from participants' self-reported questionnaire at baseline and 12 months from randomization
- Change in Diabetes Status [ Time Frame: Baseline and 12 months from randomization ]
To determine the change in diabetes status.
Outcome measure (diabetes status) will be assessed from results from participants' self-reported questionnaires and bloodwork at baseline and 12 months from randomization.
- Change in Hypertension Status [ Time Frame: Baseline and 12 months from randomization ]
To determine the change in hypertension status.
Outcome measure (hypertension status) will be assessed from results from the participants' self-reported questionnaires and physical measurements at baseline and 12 months from randomization.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01841398
|Population Health Research Institute|
|Hamilton, Ontario, Canada, L8L 2X2|
|Principal Investigator:||Sonia Anand, MD, PhD||McMaster University; Hamilton Health Sciences; Population Health Research Institute|